• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Subjective response to neuroleptics and the quality of life: implications for treatment outcome.

作者信息

Awad A G, Hogan T P

机构信息

Department of Psychiatry, University of Toronto, Ontario, Canada.

出版信息

Acta Psychiatr Scand Suppl. 1994;380:27-32. doi: 10.1111/j.1600-0447.1994.tb05828.x.

DOI:10.1111/j.1600-0447.1994.tb05828.x
PMID:7914044
Abstract

The concept of subjective response to neuroleptics in schizophrenic patients is reviewed in terms of its measurement and validity. Evidence is presented to link negative subjective response to neuroleptics to noncompliance and less favourable therapeutic outcome. The relevance of the construct of subjective responses to neuroleptics is examined in terms of its impact on the functional status and quality of life of patients. There is a great need for improved methods in researching subjective responses as well as better understanding of the factors that contribute to its genesis. The advent of new neuroleptics with superior risk-benefit ratios should encourage such research developments.

摘要

相似文献

1
Subjective response to neuroleptics and the quality of life: implications for treatment outcome.
Acta Psychiatr Scand Suppl. 1994;380:27-32. doi: 10.1111/j.1600-0447.1994.tb05828.x.
2
Subjective response to neuroleptics in schizophrenia.精神分裂症患者对抗精神病药物的主观反应。
Schizophr Bull. 1993;19(3):609-18. doi: 10.1093/schbul/19.3.609.
3
Assessment of the patient's subjective experience in acute neuroleptic treatment: implications for compliance and outcome.
Int Clin Psychopharmacol. 1996 May;11 Suppl 2:55-9. doi: 10.1097/00004850-199605002-00009.
4
Quality of life in schizophrenia: insight and subjective response to neuroleptics.
J Nerv Ment Dis. 1998 Feb;186(2):74-8. doi: 10.1097/00005053-199802000-00002.
5
Quality of life of schizophrenic patients on medications and implications for new drug trials.服用药物的精神分裂症患者的生活质量及其对新药试验的影响。
Hosp Community Psychiatry. 1992 Mar;43(3):262-5. doi: 10.1176/ps.43.3.262.
6
Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.抗精神病药物治疗精神分裂症的疗效与副作用:现有自评量表的利弊
Schizophr Res. 2009 Jul;112(1-3):114-8. doi: 10.1016/j.schres.2009.03.026. Epub 2009 Apr 23.
7
[Viewpoint of schizophrenic patients: a European survey].
Encephale. 2001 Jan-Feb;27(1):28-38.
8
[Subjective perception of the effect of neuroleptics by outpatient schizophrenic patients: a cross-sectional study].[门诊精神分裂症患者对抗精神病药物疗效的主观感受:一项横断面研究]
Encephale. 1998 Jul-Aug;24(4):315-23.
9
Subjective well-being in schizophrenia as measured with the Subjective Well-Being under Neuroleptic Treatment scale: a review.用神经阻滞剂治疗下的主观幸福感量表评估精神分裂症的主观幸福感:综述。
Aust N Z J Psychiatry. 2011 Mar;45(3):182-92. doi: 10.3109/00048674.2010.545984.
10
[Therapeutic treatment with neuroleptics. II: Subjective mechanisms of effect, compliance and consequences for treatment strategy].
Psychiatr Prax. 1991 Jan;18(1):14-20.

引用本文的文献

1
Schizophrenia and medication adherence among the population in Morocco: a cross-sectional study at the University Psychiatric Center of Casablanca.摩洛哥人口中的精神分裂症和药物依从性:卡萨布兰卡大学精神病中心的横断面研究。
Pan Afr Med J. 2024 Jul 22;48:123. doi: 10.11604/pamj.2024.48.123.39645. eCollection 2024.
2
Major Depressive Disorder (MDD) and Schizophrenia- Addressing Unmet Needs With Partial Agonists at the D2 Receptor: A Review.重性抑郁障碍(MDD)和精神分裂症-用 D2 受体部分激动剂解决未满足的需求:综述。
Int J Neuropsychopharmacol. 2019 Oct 1;22(10):651-664. doi: 10.1093/ijnp/pyz043.
3
Trajectories of Recovery Among Formerly Homeless Adults With Serious Mental Illness.
患有严重精神疾病的前无家可归成年人的康复轨迹。
Psychiatr Serv. 2016 Jun 1;67(6):610-4. doi: 10.1176/appi.ps.201500126. Epub 2016 Feb 14.
4
Antipsychotic drugs on maternal behavior in rats.抗精神病药物对大鼠母性行为的影响。
Behav Pharmacol. 2015 Sep;26(6):616-26. doi: 10.1097/FBP.0000000000000168.
5
Antipsychotic medication-induced dysphoria: its meaning, association with typical vs. atypical medications and impact on adherence.抗精神病药物引起的烦躁不安:其含义、与典型药物和非典型药物的关联以及对依从性的影响。
Psychiatr Q. 2015 Jun;86(2):199-205. doi: 10.1007/s11126-014-9319-1.
6
Sedation and disruption of maternal motivation underlie the disruptive effects of antipsychotic treatment on rat maternal behavior.镇静作用以及对母性行为动机的破坏是抗精神病药物治疗对大鼠母性行为产生破坏作用的潜在原因。
Pharmacol Biochem Behav. 2009 Mar;92(1):147-56. doi: 10.1016/j.pbb.2008.11.006. Epub 2008 Nov 17.
7
Insight, quality of life, and functional capacity in middle-aged and older adults with schizophrenia.中年及老年精神分裂症患者的洞察力、生活质量和功能能力
Int J Geriatr Psychiatry. 2008 Jul;23(7):760-5. doi: 10.1002/gps.1978.
8
The new paradigm of recovery from schizophrenia: cultural conundrums of improvement without cure.精神分裂症康复的新范式:无法治愈却有改善的文化难题。
Cult Med Psychiatry. 2005 Dec;29(4):379-413. doi: 10.1007/s11013-006-9000-8.
9
Effects of novel antipsychotics, amisulpiride and aripiprazole, on maternal behavior in rats.新型抗精神病药物氨磺必利和阿立哌唑对大鼠母性行为的影响。
Psychopharmacology (Berl). 2005 Sep;181(3):600-10. doi: 10.1007/s00213-005-0091-7. Epub 2005 Oct 12.
10
Impact of atypical antipsychotics on quality of life in patients with schizophrenia.非典型抗精神病药物对精神分裂症患者生活质量的影响。
CNS Drugs. 2004;18(13):877-93. doi: 10.2165/00023210-200418130-00004.